Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases

Abstract Background While the indications for surgery among patients with colorectal cancer liver metastases (CRCLM) are expanding, the role of surgery in patients with hepatic lymph node involvement remains controversial. We report management and outcomes in a population-based cohort of patients un...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of surgical oncology Vol. 43; no. 2; pp. 322 - 329
Main Authors Nanji, Sulaiman, Dr, Tsang, Melanie E., MD, Wei, Xuejiao, MSc, Booth, Christopher M., MD
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background While the indications for surgery among patients with colorectal cancer liver metastases (CRCLM) are expanding, the role of surgery in patients with hepatic lymph node involvement remains controversial. We report management and outcomes in a population-based cohort of patients undergoing hepatectomy with concomitant hepatic lymphadenectomy for CRCLM. Methods All cases of hepatectomy for CRCLM in the Canadian Province of Ontario from 2002-2009 were identified using the population-based Ontario Cancer Registry and linked electronic records of treatment. Pathology reports were used to identify concomitant lymphadenectomy with liver resection as well as extent of disease and surgical procedure. Results Among 1310 patients who underwent resection for CRCLM, 103 (8%) underwent simultaneous regional lymphadenectomy. Seventy-one percent of cases with lymphadenectomy (70/103) had a major liver resection (≥3 segments). Of the 103 lymphadenectomy cases, 80 (78%) were hepatic pedicle, 16 (16%) were celiac and 7 (7%) were para-aortic. The mean number of nodes removed was 2.2 (range 1-15). Ninety-day mortality was 6%. Twenty-nine percent (30/103) of cases had positive nodes. Unadjusted overall survival at 5 years for positive vs negative nodes was 21% vs 42% (p=0.003); cancer-specific survival was 10% vs 43% (p<0.001). In adjusted analyses, hepatic node involvement was associated with inferior OS (HR 2.19, p=0.010) and CSS (HR 3.07, p=0.002). Conclusions Patients with resected CRC liver metastases with regional lymph node involvement have inferior survival compared to patients with negative nodes. Despite this poor prognostic factor, a small proportion of cases with involved nodes will achieve long-term survival.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2016.10.033